EUVIMEDEUVIMED entdecken
Crossref

Gastrointestinal segmental remission with oral budesonide therapy for eosinophilic gastrointestinal diseases

Mian B Khalid, Disha Sharma, Amari Howard, Dilara Akbulut, Michelly Sampaio de Melo, Martha M Quezado, Perla A Castillo, Gustavo A Cuevas, Amy D Klion, Paneez Khoury, Gregory M Constantine, Sheila Kumar

The Journal of Allergy and Clinical Immunology: In Practice · 2024

DOI: 10.1016/j.jaip.2024.06.028 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Allergy and Clinical Immunology: In Practice, 2024. Verfasst von Mian B Khalid und 11 weiteren Autor:innen. Beteiligte Einrichtung: National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Md. Hauptthemen laut MEDLINE: Budesonide, Enteritis, Eosinophilia, Gastritis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 8 Literaturangaben. Gefördert von: National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BudesonideEnteritisEosinophiliaGastritisAdultFemaleHumansMaleMiddle AgedAdministration, OralRemission InductionTreatment OutcomeChild, PreschoolAdolescentYoung Adult

Substanzen

Budesonide

Autor:innen und Institutionen

  • National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Md.
  • National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.
  • National Cancer Institute, National Institutes of Health, Bethesda, Md.
  • National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Md. Electronic address: sheila.kumar@nih.gov.

Förderung

  • National Institute of Diabetes and Digestive and Kidney Diseases
  • National Institute of Allergy and Infectious Diseases

Zitieren

APA

Khalid, M. B., Sharma, D., Howard, A., Akbulut, D., Sampaio de Melo, M., Quezado, M. M., Castillo, P. A., Cuevas, G. A., Klion, A. D., Khoury, P., Constantine, G. M., & Kumar, S. (2024). Gastrointestinal segmental remission with oral budesonide therapy for eosinophilic gastrointestinal diseases. The Journal of Allergy and Clinical Immunology: In Practice. https://doi.org/10.1016/j.jaip.2024.06.028

Vancouver

Khalid MB, Sharma D, Howard A, Akbulut D, Sampaio de Melo M, Quezado MM, et al. Gastrointestinal segmental remission with oral budesonide therapy for eosinophilic gastrointestinal diseases. The Journal of Allergy and Clinical Immunology: In Practice. 2024. doi:10.1016/j.jaip.2024.06.028

BibTeX
@article{Khalid2024,
  author = {Khalid, Mian B and Sharma, Disha and Howard, Amari and Akbulut, Dilara and Sampaio de Melo, Michelly and Quezado, Martha M and Castillo, Perla A and Cuevas, Gustavo A and Klion, Amy D and Khoury, Paneez and Constantine, Gregory M and Kumar, Sheila},
  title = {Gastrointestinal segmental remission with oral budesonide therapy for eosinophilic gastrointestinal diseases},
  journal = {The Journal of Allergy and Clinical Immunology: In Practice},
  year = {2024},
  doi = {10.1016/j.jaip.2024.06.028}
}
Kostenlos starten →